These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

662 related items for PubMed ID: 7585774

  • 41. Comparative study on the short-term effects of angiotensin converting enzyme inhibitors (Lopirin, SQUIBB and Tensiomin), and dihydralazine in chronic cardiac failure.
    Dékány M, Bányai F, Antalóczy Z.
    Acta Physiol Hung; 1988; 72 Suppl():93-110. PubMed ID: 3075406
    [Abstract] [Full Text] [Related]

  • 42. Early or late ACE inhibition after myocardial infarction.
    Ball SG.
    J Cardiovasc Pharmacol; 1993; 22 Suppl 9():S18-21. PubMed ID: 7514236
    [Abstract] [Full Text] [Related]

  • 43. [ACE inhibitors in the treatment of patients with acute myocardial infarct].
    Borghi C, Ambrosioni E.
    Ann Ital Med Int; 1995; 10(3):175-87. PubMed ID: 7577315
    [Abstract] [Full Text] [Related]

  • 44. Effect of angiotensin-converting enzyme inhibitors in left ventricular dysfunction: results of the studies of left ventricular dysfunction in the context of other similar trials.
    Yusuf S, Garg R, McConachie D.
    J Cardiovasc Pharmacol; 1993; 22 Suppl 9():S28-35. PubMed ID: 7514238
    [Abstract] [Full Text] [Related]

  • 45. Congestive heart failure: new therapeutic strategies.
    Pitt B.
    Clin Cardiol; 1992 Sep; 15 Suppl 1():I2-4. PubMed ID: 1395211
    [Abstract] [Full Text] [Related]

  • 46. [Prevention with angiotensin-converting enzyme (ACE) inhibitors].
    Ertl G, Gaudron P, Neubauer S, Bauer B.
    Z Kardiol; 1992 Sep; 81 Suppl 4():205-10. PubMed ID: 1290300
    [Abstract] [Full Text] [Related]

  • 47. [Possibilities of ACE inhibitor therapy in acute myocardial ischemia].
    Ertl G, Bauer B, Gaudron P, Neubauer S, Schorb W, Kochsiek K.
    Klin Wochenschr; 1991 Sep; 69 Suppl 24():10-7; discussion 18-9. PubMed ID: 1865631
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Angiotensin converting enzyme inhibition therapy following myocardial infarction. Rationale for clinical trials.
    Pfeffer MA.
    Herz; 1991 Sep; 16 Spec No 1():278-82. PubMed ID: 1840297
    [Abstract] [Full Text] [Related]

  • 52. Serum cholesterol levels on admission and survival in patients with acute myocardial infarction treated with zofenopril: a post hoc analysis of the Survival of Myocardial Infarction Long-term Evaluation trial.
    Borghi C, Cicero AF, Bacchelli S, Esposti DD, Ambrosioni E, Survival of Myocardial Infarction Long-term Evaluation (SMILE) Study.
    Fundam Clin Pharmacol; 2009 Oct; 23(5):641-8. PubMed ID: 19656211
    [Abstract] [Full Text] [Related]

  • 53. [Heart insufficiency and life expectancy--the role of ACE inhibitors].
    Kleber FX.
    Wien Med Wochenschr; 1990 Jan 31; 140(1-2):50-5. PubMed ID: 2408250
    [Abstract] [Full Text] [Related]

  • 54. Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach.
    Zeymer U, Jünger C, Zahn R, Bauer T, Bestehorn K, Senges J, Gitt A.
    Curr Med Res Opin; 2011 Aug 31; 27(8):1563-70. PubMed ID: 21682553
    [Abstract] [Full Text] [Related]

  • 55. ACE inhibitors in heart failure: an update.
    Smith WH, Ball SG.
    Basic Res Cardiol; 2000 Aug 31; 95 Suppl 1():I8-14. PubMed ID: 11192359
    [Abstract] [Full Text] [Related]

  • 56. Improving outcome after acute myocardial infarction: what is the role of ACE inhibitors?
    Purcell H, Coats A, Fox K, Campbell R.
    Br J Clin Pract; 1995 Aug 31; 49(4):195-9. PubMed ID: 7547161
    [Abstract] [Full Text] [Related]

  • 57. Angiotensin-converting enzyme inhibitors in heart failure: a role after myocardial infarction.
    Sharpe N.
    J Cardiovasc Pharmacol; 1991 Aug 31; 18 Suppl 2():S99-104. PubMed ID: 1725054
    [Abstract] [Full Text] [Related]

  • 58. Acute administration of angiotensin converting enzyme inhibitors in thrombolysed myocardial infarction patients is associated with a decreased incidence of heart failure, but an increased re-infarction risk.
    Voors AA, de Kam PJ, van den Berg MP, Borghi C, Hochman JS, van Veldhuisen DJ, van Gilst WH.
    Cardiovasc Drugs Ther; 2005 Mar 31; 19(2):119-24. PubMed ID: 16025230
    [Abstract] [Full Text] [Related]

  • 59. The problem of underdosing of angiotensin-converting enzyme inhibitors is markedly overrated: results from a study of patients discharged from hospital after an acute myocardial infarction.
    Kvan E, Reikvam A, INPHARM Study Investigators.
    Eur J Clin Pharmacol; 2004 May 31; 60(3):205-10. PubMed ID: 15034703
    [Abstract] [Full Text] [Related]

  • 60. Captopril. A review of its pharmacology and therapeutic efficacy after myocardial infarction and in ischaemic heart disease.
    Plosker GL, McTavish D.
    Drugs Aging; 1995 Sep 31; 7(3):226-53. PubMed ID: 8535052
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.